| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.067 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |